Tatva Chintan Pharma Chem Limited

About the company

Established in 1996, Gujarat-based Tatva Chintan Pharma Chem is a specialty chemicals manufacturer with a diverse portfolio of 154 products. The company makes structure directing agents (SDAs), phase transfer catalysts (PTCs), pharmaceutical and agrochemical intermediates. These chemicals are used in various sectors including automotive, petroleum, dyes and pigments, paints and coatings and personal care. Tatva Chintan Pharma is an export-oriented company, with 70% of its total revenue coming from overseas markets, including the US, China and South Africa.The company has reported strong growth over the past three years. Its revenue and net profit have surged at a CAGR of 20.5% and 59.5%, respectively, during FY19–21.

Financial performance (₹ Cr)

IPO Roadmap / Timeline

1. IPO Opens

   Completed
   16 Jul 2021

   Bidding starts for all investor categories

2. IPO Closes

   Completed
   20 Jul 2021

   Last day to place your bid

3. Basis of Allotment

   Completed
   18 Jul 2021

   Share allotment finalised

4. Refund Initiation

   Completed
   27 Jul 2021

   Refunds credited for non-allottees

5. Credit to Demat

   Completed
   26 Jul 2021

   Allotted shares credited to demat account

6. Listing on Exchange

   Completed
   29 Jul 2021

   Shares list on NSE / BSE

Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.